The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ASCO 2018 | Choosing the best treatment for your follicular lymphoma patient
Speaking from the American Society of Oncology (ASCO) 2018 Annual Meeting in Chicago, IL, Nathan Fowler, MD, of the MD Anderson Cancer Center, Houston, TX, discusses the decision-making process when selecting the best frontline treatment for a follicular lymphoma patient. Prof. Fowler highlights the factors that should be taken into consideration, including specific comorbities, disease progression and side effects.
